Newsletter Subscription


Tuesday, April 21, 2015


Implant Sciences Receives Patent for Narcotics and Explosives Particle Removal System

  • Company Continues to Build Patent Portfolio and Strengthen IP Position

WILMINGTON, MA, Mar 21, 2012 (MARKETWIRE via COMTEX) --Implant Sciences Corporation (OTCQB: IMSC) (PINKSHEETS: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced that it has been issued patent number 8,122,756 from the US Patent and Trademark Office. The patent, titled, "Narcotics and Explosives Particle Removal System," covers a method for removing particles from a target surface to increase sample collection.

Todd Silvestri, Implant Sciences' Vice President of Technology, commented, "Non-contact sample collection enables a wider range of deployment options for trace detection technologies. This invention is aimed at improving the collection efficiency of our non-contact sampling technologies."


Related Research on ASDReports.com:
Analysis of the Global Face Biometrics Market

Implant Sciences President and CEO Glenn D. Bolduc added, "This latest patent, the twelfth we have received, reaffirms Implant Sciences' commitment to being a true innovator in explosives and narcotics trace detection. New technologies that we have introduced include non-radioactive ionization, non-contact sampling, and automatic self-calibration. The breakthroughs made by our technology group continue to open new market opportunities for the Company and build shareholder value."

Your company’s press release on ASDNews and to thousands of other journalists and editors? Use our ASDWire press release distribution service.

Source : Implant Sciences Corp.

Published on ASDNews: Mar 22, 2012

 

Additive Manufacturing for Defense and Aerospace Conference

Aug 31 - Sep 2, 2015 - Washington, United States

Register More info


Helicopter Technology Eastern Europe 2015 Conference

Jun 24 - 25, 2015 - Prague, Czech Republic

Register More info


© 2004-2015 • ASDNews • be the first to know • contact usterms & conditionsprivacy policyadvertisingfaqs

zpsk